✦ LIBER ✦

A phase II study of temozolomide therapy for poor-risk patients aged 60 years with acute myeloid leukemia: low levels of MGMT predict for response

✍ Scribed by Brandwein, J M; Yang, L; Schimmer, A D; Schuh, A C; Gupta, V; Wells, R A; Alibhai, S M H; Xu, W; Minden, M D

Book ID: 110057061
Publisher: Nature Publishing Group
Year: 2007
Tongue: English
Weight: 103 KB
Volume: 21
Category: Article
ISSN: 0887-6924
DOI: 10.1038/sj.leu.2404545

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I study of tipifarnib combined w

A phase I study of tipifarnib combined with conventional induction and consolidation therapy for previously untreated patients with acute myeloid leukemia aged 60 years and over

✍ Brandwein, J M; Leber, B F; Howson-Jan, K; Schimmer, A D; Schuh, A C; Gupta, V; 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 100 KB

Continuous infusion of intermediate-dose

Continuous infusion of intermediate-dose cytarabine and fludarabine with idarubicin for patients younger than 60 years with resistant acute myeloid leukemia: A prospective, multicenter phase II study

✍ Hawk Kim; Jae-Hoo Park; Je-Hwan Lee; Jung-Hee Lee; Young-Don Joo; Won-Sik Lee; S 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 3 views

A randomized phase-I/II multicenter stud

A randomized phase-I/II multicenter study of recombinant human granulocyte-macrophage colony-stimulating factor (GM-CSF) therapy for patients with myelodysplastic syndromes and a relatively low risk of acute leukemia

✍ R. Willemze; N. van der Lely; H. Zwierzina; S. Suciu; G. Solbu; H. Gerhartz; B. 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 36 KB

A randomized phase-I/II multicenter stud

✍ R. Willemze; N. van der Lely; H. Zwierzina; S. Suciu; G. Solbu; H. Gerhartz; B. 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 753 KB